Eric M. Dube, CHIEF EXECUTIVE OFFICER at Travere Therapeutics, Inc. (TVTX), sold 120,000 shares at $30.01 ($3.6M) on 2026-01-23, disclosed to the SEC on 2026-01-27.
Seasonal sale ($3.6M) by CHIEF EXECUTIVE OFFICER — this insider has traded TVTX in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.01 | 8,135 | $244K | 6.8% |
| 2 | $30.01 | 8,135 | $244K | 6.8% |
| 3 | $30.10 | 51,865 | $1.6M | 43.2% |
| 4 | $30.10 | 51,865 | $1.6M | 43.2% |
| Total | $30.09 avg | 120,000 | $3.6M | 100% |
| Filing → |
| TVTX | SELL | 2026-04-15 | $2.6M | — | Filing → |
| TVTX | SELL | 2026-04-02 | $1.9M | — | Filing → |
| TVTX | SELL | 2026-02-24 | $1.8M | — | Filing → |